Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5673134 | Journal of Virological Methods | 2017 | 7 Pages |
Abstract
The results of this study showed that EBOV spiked into human serum was not fully inactivated when treated with either 0.1% (v/v) Triton X-100 for 10 mins or 1.0% (v/v) Triton X-100 for 20 mins (final concentrations 0.08% and 0.8% Triton X-100 respectively). AVL alone also did not consistently provide complete inactivation. Samples treated with both AVL and 0.1% Triton X-100 for 10 or 20 mins were shown to be completely inactivated. This treatment is compatible with downstream analysis by RT-qPCR and next generation sequencing.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
J.E. Burton, L. Easterbrook, J. Pitman, D. Anderson, S. Roddy, D. Bailey, R. Vipond, C.B. Bruce, A.D. Roberts,